Consolidation

UPDATE

UPDATES from DIA 2012: "Collaborate to innovate," says the association

27-Jun-2012 - “Collaborate to innovate,” is the message DIA has for clinical researchers at its 2012 Annual Meeting in Philadelphia, US.

Catalent and Bend partner on oral controlled-release development

25-Jun-2012 - Catalent and Bend Research have joined forces to tackle time and cost restrictions for the complex oral controlled-release development and manufacturing process.

SAFC pieces together services for fuller chiral offering

13-Jun-2012 - SAFC has coupled its chiral screening and small-scale purification services to meet what it says is a boom in demand for more complete chemical analysis from drugmakers.

PRA refinancing gives financial flexibility for acquisitions; S&P

11-Jun-2012 - S&P thinks PRA will use the flexibility in its new credit facility to grow its business through acquisitions.

inVentiv buys Kazaam to boost digital commercial services

07-Jun-2012 - inVentiv Health will expand its digital and social media commercial services following the takeover of Kazaam Interactive.

Round up of CMO M&A

05-Jun-2012 - Outsourcing-Pharma presents a roundup of M&A activity in the CMO space, including Piramal on the hunt for deals and Siegfried buying AMP.

Kemwell and Boehringer set to finish biologics plant in India

29-May-2012 - Kemwell is set to complete a new biologics manufacturing facility in Bangalore, India, following its long-term partnership with Boehringer Ingelheim.

EXCLUSIVE

Chiltern CEO reflects on 30 years in the CRO biz

28-May-2012 - More than a third of patient recruitment will be done in emerging markets in the future, predicts Chiltern CEO Glenn Kerkhof.

Contract sales sector “shrunk” in 2011, PDI CEO says

21-May-2012 - The CEO of PDI said the contract sales market has “shrunk” over the past few quarters as the flow of business awards has dried up.

FDA oversight driving closures of CMOs; Interphex speaker

09-May-2012 - Increased oversight by the FDA is causing some US-based CMOs to shut down, a speaker at Interphex said.

Charles River CEO downplays interest in asset transfer deals

07-May-2012 - The CEO of Charles River said asset transfer strategic deals make little “rational sense” to clients or CROs.

Exclusive interview

Once a friend now an enemy: Over zealous EU regulators could hamper the CMO market, says analyst

25-Apr-2012 - The European CMO industry could be blocked by over complex layers of regulation, says Frost & Sullivan analyst Aiswariya Chidambaram.

Regulatory changes: the experts give us their thoughts at DIA Euromeeting

05-Apr-2012 - Regulatory reform was the name of the game at this year’s DIA Euromeeting in Denmark.

INC & inVentiv must integrate buys quickly to compete; S&P

03-Apr-2012 - INC Research and inVentiv Health must “quickly and effectively” integrate acquisitions to compete with other CROs, S&P said.

Sigma-Aldrich plans targeted models to expand service biz

03-Apr-2012 - Sigma-Aldrich plans to grow its new biologics toxicology services unit by creating targeted cell lines and animal models.

'Regulators: Get to the point', say experts at DIA Euromeeting

29-Mar-2012 - “Less bureaucracy and more research” was the Danish Minister of science and innovation’s message to regulators at this week's DIA Euromeeting.

Cetero eyes fast sale to private equity as FDA agreement nears

29-Mar-2012 - Cetero says it could have new private equity owners in 90 days and an agreed path forward with the FDA in weeks.

SEC filing sparks speculation PE firm plans Medidata takeover

19-Mar-2012 - A SEC filing has created speculation that Medidata is the target of a private equity takeover attempt by Vista Equity Partners.

European CMO market will double in just 6 years, says Frost & Sullivan

15-Mar-2012 - The European CMO sector is set to double in the next six years and will hit revenues of up to $20.75bn, according to Frost & Sullivan’s Aiswariya Chidambaram.

Patheon posts $21m dip thanks to loss of major manufacturing deal

13-Mar-2012 - Patheon took a $20.9m (€15.9m) Q1 hit in operating costs thanks to the loss of a major manufacturing supply agreement.

Private equity to buy SeraCare

14-Feb-2012 - SeraCare Life Sciences has accepted an $82m offer from a US private equity firm six months after it began searching for a buyer.

Covance looking to win biz from distracted competitors; analyst

07-Feb-2012 - Covance is investing to win business from “distracted competitors” that have been part of mergers and buyouts, an analyst claims.

Takeovers & tox top agendas as preclinical CROs’ results near

24-Jan-2012 - Preclinical CROs begin reporting full year results this week, with talk of takeovers and toxicology high on agendas.

Outsourcing still a gamble that needs strategic vision to succeed, says study

24-Jan-2012 - Outsourcing is a gamble for the industry that needs a closer collaborative approach if pharma firms want a successful performance, according to new research.

Polytherics buys Warwick Effect Polymers for biodrug modification tech

23-Jan-2012 - UK-based Polytherics has acquired Warwick Effect Polymers (WEP) to expand biologic drug modification offering.